Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

December 03, 2024 05:20 ET | Source: Research and Markets

Pharmaceutical CRO Market Report 2025-2030, Featuring Parexel, ICON, Laboratory Corporation of America, Thermo Fisher Scientific, Medpace, IQVIA, WuXi AppTec and Veeda Clinical Research

Dublin, Dec. 03, 2024 (GLOBE NEWSWIRE) -- The "Pharmaceutical CRO Market Size, Share & Trends Analysis Report by Type (Drug Discovery, Pre-Clinical, Clinical), Molecule Type (Small Molecules,...
November 21, 2024 11:30 ET | Source: Research and Markets

Patient Derived Xenograft (PDX) Models Market Expects Significant Growth, Reaching $710 Million by 2028 - Global Long-term Forecasts to 2033

Dublin, Nov. 21, 2024 (GLOBE NEWSWIRE) -- The "Patient Derived Xenograft (PDX) Models Market Report 2024" report has been added to ResearchAndMarkets.com's offering. The patient derived...
January 30, 2024 05:20 ET | Source: Research and Markets

Global Patient-Derived Xenograft/PDX Model Market Set to Expand with Growing Emphasis on Personalized Medicine and Cancer Research

Dublin, Jan. 30, 2024 (GLOBE NEWSWIRE) -- The "Patient-Derived Xenograft/PDX Model Market by Type (Mice, Rat), Implantation Method (Subcutaneous, Orthotopic), Tumor Type (Respiratory,...
November 14, 2023 03:13 ET | Source: Research and Markets

Pharmacokinetics Services Market Report 2023: A Global $1.75+ Billion Industry by 2030 - Analysis by Drug Type (Small Molecules) & End-use (Biotechnology & Pharmaceutical Companies)

Dublin, Nov. 14, 2023 (GLOBE NEWSWIRE) -- The "Pharmacokinetics Services Market Size, Share & Trends Analysis Report By Drug Type (Small Molecules), By Application (SMEs) By End-use...
May 17, 2023 04:28 ET | Source: Research and Markets

Early Toxicity Testing Global Market Report 2023: Growth in Prevalence of Chronic Diseases and Need for New Treatments Fuels Sector

Dublin, May 17, 2023 (GLOBE NEWSWIRE) -- The "Early Toxicity Testing Market by Technique, by Toxicity Endpoint, by End User - Global Opportunity Analysis and Industry Forecast, 2023-2030" report has...
April 20, 2023 09:18 ET | Source: Research and Markets

Asia-Pacific Pharmaceutical Industry Outlook Report 2023-2027: Top Predictions, Key Trends, Macroeconomic Factors, Revenues, Country-specific Trends, Opportunities

Dublin, April 20, 2023 (GLOBE NEWSWIRE) -- The "Asia-Pacific Pharmaceutical Industry Outlook 2023" report has been added to ResearchAndMarkets.com's offering. Asia-Pacific's pharmaceutical market...
December 14, 2022 04:18 ET | Source: Research and Markets

Global Contract Research Organization (CRO) Market Analysis Report 2022: Strong Competitive Intensity is Mandating a Greater Industry Convergence Resulting in a Strong Market Growth

Dublin, Dec. 14, 2022 (GLOBE NEWSWIRE) -- The "Global Contract Research Organization (CRO) Growth Opportunities" report has been added to ResearchAndMarkets.com's offering. The COVID-19 pandemic...
September 05, 2022 06:33 ET | Source: Research and Markets

Global Pharma ADMET Testing Markets, 2022-2028: Advent of High-Throughput Screening & Opportunities in Automation and Advancements in ADME Testing

Dublin, Sept. 05, 2022 (GLOBE NEWSWIRE) -- The "Pharma ADMET Testing Market Forecast to 2028 - COVID-19 Impact and Global Analysis By Testing Type, Technology, and Application" report has been added...
October 08, 2020 08:05 ET | Source: Corbus Pharmaceuticals Holdings, Inc.

Corbus Pharmaceuticals Announces Corporate Restructuring and Pipeline Portfolio Updates

Company is restructuring with the goal of extending cash runway to mid-2022Workforce to be reduced by 54%Company to focus on completing Phase 3 dermatomyositis study and advancing preclinical pipeline...
September 09, 2014 03:00 ET | Source: OnCore Biopharma, Inc.

OnCore Biopharma Licenses Second-Generation Cyclophilin Inhibitors From NeuroVive for the Treatment of Chronic HBV Infection

OnCore Secures Exclusive Worldwide Rights to NVP018 NVP018 Will Complement OnCore's Existing Pipeline Directed at Achieving All-Oral Cure for HBV DOYLESTOWN, Pa., Sept. 9, 2014 (GLOBE NEWSWIRE)...